Argipressin or vasopressin

This classification denotes antidiuretic hormones released by the neurohypophysis of all vertebrates (structure varies with species) to regulate water balance and osmolarity, most especially arginine vasopressin, which typically arises in the molecular formula C46H65N15O12S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y87Y826H08, chemically known as 1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide but generally known as vasopressin, which bears US NIH Compound Identifier 8230. European Medicines Agency schedules Vasopressin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20776. The term VASOPRESSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7.). World Health Organization schedules vasopressin in its Anatomical Therapeutic Chemical (ATC) Classification. Argipressin or vasopressin bears US NLM identifiers UMLS ID C0003779 and NCI Concept Code C926. SMILES: C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N.